原发性肝癌的中西医研究进展

Research Progress in Traditional Chinese and Western Medicine for Primary Liver Cancer

目前原发性肝癌依旧是我国高发的恶性肿瘤之一,致死率也高居不下,对我国国民的身体健康存在着严重的威胁。近年来随着对肝恶性肿瘤的检查方式和治疗药物的不断更新发展,提高了我们对疾病的认知,进一步指导了肝恶性肿瘤的诊疗方案,也逐渐认识到治疗肝恶性肿瘤的多样化,从单纯的西医治疗慢慢加入中医辅助治疗从而过渡到中西医结合治疗,从局部治疗过渡到整体治疗,相辅相成地提高肝恶性肿瘤患者的治疗效果,改善患者的生存质量,延长患者的生存时间。*通讯作者。At present, primary liver cancer is still one of the most common malignant tumors in China, and the mortality rate is also high, which poses a serious threat to the health of Chinese people. In recent years, with the continuous updating and development of examination methods and therapeutic drugs for liver malignant tumors, our understanding of the disease has been improved, and the diagnosis and treatment plan of liver malignant tumors has been further guided, and the diversification of the treatment of liver malignant tumors has been gradually recognized. Starting from simple Western medicine treatment, gradually Joining traditional Chinese medicine as an adjuvant therapy to transition to integrated traditional Chinese and Western medicine treatment, and transitioning from local treatment to holistic treatment, complement each other to improve liver malignancy. The treatment effect of tumor patients improves their quality of life and prolongs their survival time.